[Olaparib and pancreatic cancer: A challenging Lesson]. [electronic resource]
Producer: 20190918Description: 715-716 p. digitalISSN:- 1769-6917
- Adenocarcinoma -- drug therapy
- Antineoplastic Agents -- therapeutic use
- Clinical Trials, Phase III as Topic
- Genes, BRCA1
- Genes, BRCA2
- Germ-Line Mutation
- Humans
- Pancreatic Neoplasms -- drug therapy
- Phthalazines -- therapeutic use
- Piperazines -- therapeutic use
- Placebos
- Progression-Free Survival
- Randomized Controlled Trials as Topic
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.